Pet Obesity Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type (Dogs, Cats, Others), By Product (Therapeutic Food, Supplements), By Distribution Channel (Pet Specialty Stores, E-Commerce, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 11.61 Billion
CAGR (2026-2031)	6.73%
Fastest Growing Segment	Supplements
Largest Market	North America
Market Size (2031)	USD 17.16 Billion

Market Overview

The Global Pet Obesity Management Market will grow from USD 11.61 Billion in 2025 to USD 17.16 Billion by 2031 at a 6.73% CAGR. The Global Pet Obesity Management Market consists of therapeutic nutritional formulations, pharmaceutical interventions, and physical rehabilitation services designed to reduce excess body weight in companion animals. The market is primarily driven by the increasing humanization of pets and a deepening understanding of obesity-related comorbidities such as osteoarthritis and diabetes among owners. Furthermore, the sector benefits from the rising prevalence of sedentary lifestyles in pets which necessitates professional weight management solutions to ensure longevity and quality of life.

Despite these growth factors, a significant challenge hinders market expansion regarding the disparity between actual pet health and owner perception. Many owners fail to correctly identify overweight conditions, which leads to a lack of early treatment and low compliance with dietary restrictions. According to the Association for Pet Obesity Prevention, in 2024, 35% of dog owners and 33% of cat owners categorized their pets as overweight or having obesity. This statistic highlights the gap between clinical reality and owner recognition that restricts the potential consumer base for professional management products.

Key Market Drivers

The rising global prevalence of pet obesity is the primary force expanding the market, creating an urgent clinical necessity for professional weight management interventions. As sedentary lifestyles and caloric overconsumption become normalized among companion animals, the incidence of weight-related pathologies such as osteoarthritis and metabolic dysfunction has surged, compelling veterinary professionals to prescribe rigorous weight management protocols. This escalating health crisis creates a direct, non-discretionary demand for specialized low-calorie formulations and physical rehabilitation services, establishing the baseline volume for market growth. According to UK Pet Food, October 2024, in the 'Obesity Report 2024', veterinary professionals estimate that 50% of dogs and 43% of cats in the United Kingdom are currently overweight or obese.

Simultaneously, rising disposable income and pet healthcare expenditure play a critical role in converting this medical need into realized market revenue. As the trend of pet humanization deepens, owners are increasingly willing to allocate substantial financial resources toward premium veterinary care and prescription diets to extend the lifespan of their animal companions. According to the American Pet Products Association, March 2024, in the '2024-2025 National Pet Owners Survey', total U.S. pet industry expenditures reached $147 billion in 2023, reflecting a robust capacity for healthcare spending. This financial readiness allows for the adoption of higher-cost solutions beyond standard kibble restriction. The market relevance of this spending capacity is evident in consumer behavior regarding specific treatments; according to the Association for Pet Obesity Prevention, May 2024, in the '2023 U.S. Pet Obesity Prevalence Survey', 16% of dog owners and 25% of cat owners reported utilizing a therapeutic weight-loss diet for their pets.

Download Free Sample Report

Key Market Challenges

The significant disparity between actual pet body condition and owner perception acts as a primary restraint on the Global Pet Obesity Management Market. This cognitive disconnect directly limits market penetration because owners who do not recognize weight issues are unlikely to purchase therapeutic nutritional formulations or seek pharmaceutical interventions. The failure to identify excess weight precludes the veterinary consultation required to prescribe management solutions, effectively rendering a large portion of the clinically addressable population inaccessible to manufacturers. Without accurate recognition, the demand for specialized products remains suppressed despite the high prevalence of the condition.

Data from industry associations substantiates the magnitude of this obstacle. According to UK Pet Food, in 2024, veterinary professionals classified 50% of dogs and 43% of cats as overweight or obese, whereas 77% of owners believed their pets were at a healthy weight. This contrast demonstrates that a vast majority of potential consumers are unaware of their pet's medical needs, preventing the market from capitalizing on the actual volume of obesity cases. Consequently, revenue growth is hampered not by a lack of effective treatments, but by the fundamental inability of the end-user to acknowledge the problem.

Key Market Trends

The development of GLP-1 receptor agonist medications for pets represents a transformative shift in the market, moving beyond traditional caloric restriction toward pharmaceutical interventions that mirror human obesity treatments. This trend leverages the biological conservation of the GLP-1 receptor to formulate long-acting injectables that regulate appetite and improve metabolic function without requiring strict owner compliance to dietary measuring. The potential for rapid adoption is high, as owners are increasingly open to medicalizing weight loss for their companions to mitigate health risks. According to PetfoodIndustry, April 2025, in the article 'Survey reveals gaps in pet obesity awareness, owner-vet communication', roughly one in three pet owners said they would consider using a prescription weight-loss drug for their pets if proven safe and effective.

The adoption of wearable pet activity trackers is simultaneously reshaping weight management strategies by providing objective data on energy expenditure to combat sedentary behaviors. Unlike subjective owner observations, these devices utilize accelerometer technology to monitor activity levels and caloric burn, enabling veterinarians to prescribe precise exercise regimens based on real-time metrics. This technology creates a feedback loop that encourages owner engagement and adherence to rehabilitation protocols. The scale of this integration is evident in the growing user base of leading device manufacturers; according to Tractive, January 2025, in the 'A Deep Dive into Tractive's Latest Tech' interview, the company reported having over 1.3 million active subscribers utilizing their tracking solutions.

Segmental Insights

The Supplements segment is widely identified as the fastest-growing category within the Global Pet Obesity Management Market. This rapid expansion is primarily driven by the "humanization" of pets, prompting owners to prioritize preventative healthcare and proactive weight control strategies. Consumers are increasingly shifting toward natural, functional ingredients such as probiotics and fiber-rich compounds to support metabolism, a trend often aligned with nutritional awareness campaigns from institutions like the Association for Pet Obesity Prevention. Furthermore, the convenience of over-the-counter availability and the rise of e-commerce channels allow owners to easily integrate these weight management solutions into daily dietary regimes, fueling substantial segment momentum.

Regional Insights

North America maintains a leading position in the global pet obesity management market, driven by substantial pet ownership and rising expenditure on veterinary care. The region benefits from a strong focus on animal health and established regulatory frameworks, such as those maintained by the U.S. Food and Drug Administration and the Association of American Feed Control Officials. These organizations enforce rigorous standards for pet nutrition and pharmaceuticals, ensuring product reliability. Consequently, high consumer confidence and the prioritization of pet wellness sustain the regional demand for specialized weight management solutions.

Recent Developments

• In May 2025, Royal Canin released the results of a comprehensive global research study highlighting significant misconceptions among pet owners regarding obesity. The data revealed that a large percentage of owners failed to recognize their pets as overweight, despite a reported global rise in pet obesity cases following the pandemic. The company launched a campaign titled "ScalingTheConversation" to bridge the communication gap between veterinary professionals and pet parents. This research emphasized the critical need for science-based nutritional advice and professional guidance to ensure pets maintained a healthy weight and to prevent severe complications associated with excess body fat.
• In February 2025, Hill's Pet Nutrition established a strategic partnership with the Association for Pet Obesity Prevention (APOP) to combat the rising global rates of pet obesity. This collaboration focused on equipping veterinary teams with improved communication strategies and educational resources to facilitate constructive conversations with pet owners about healthy weight management. The initiative was part of a broader campaign to promote evidence-based treatments and address the gap in owner awareness regarding their pets' body condition. By combining professional guidance with nutritional solutions, the organizations aimed to improve long-term health outcomes for overweight pets and reduce obesity-related risks.
• In February 2024, Better Choice Company acquired Aimia Pet Healthco to advance the development of weight loss supplements for domestic animals. The company announced plans to conduct internal clinical trials for a GLP-1 based supplement, leveraging the mechanism of action found in successful human weight loss drugs. The goal of this strategic move was to create treats and food toppers that mirrored the benefits of leading obesity medications while providing essential protein and nutrients. This development marked the firm's significant entry into the GLP-1 pet market to combat the growing prevalence of obesity in dogs and cats using pharmaceutical-grade science.
• In January 2024, Hill's Pet Nutrition unveiled new product innovations within its Prescription Diet line to support weight management and other critical health needs. The launch included Prescription Diet z/d Low Fat Hydrolyzed Soy Canine and Prescription Diet c/d Multicare Low Fat Canine, which were specifically formulated to address food sensitivities and urinary health while simultaneously managing canine weight. The company highlighted these advancements at a major veterinary conference, emphasizing their science-led nutrition that utilized breakthrough ingredient technology to activate the gut microbiome. This initiative aimed to provide veterinarians with effective nutritional tools to help owners manage their pets' weight without compromising on taste.

Key Market Players

• Mars Incorporated
• Hill's Pet Nutrition, Inc.
• Nestlé S.A
• Farmina Pet Foods Holding B.V.
• Drools Pet Food Pvt. Ltd.
• NOW Health Group, Inc.
• Virbac S.A.
• VioVet Ltd
• Rolf C. Hagen Inc.
• Vivaldis Health & Foods Pvt. Ltd.
• Neogen Corporation

By Animal Type	By Product	By Distribution Channel	By Region
Dogs Cats Others	Therapeutic Food Supplements	Pet Specialty Stores E-Commerce Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Pet Obesity Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Pet Obesity Management Market, By Animal Type:

• Dogs
• Cats
• Others

• Pet Obesity Management Market, By Product:

• Therapeutic Food
• Supplements

• Pet Obesity Management Market, By Distribution Channel:

• Pet Specialty Stores
• E-Commerce
• Others

• Pet Obesity Management Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE